(Q48492118)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22278360%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Quality of life during dendritic cell vaccination against metastatic renal cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22278360%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22278360%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Nicolai Leonhartsberger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22278360%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Reinhold Ramoner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22278360%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Claudia Falkensammer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22278360%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Andrea Rahm

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22278360%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Hubert Gander

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22278360%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Lorenz Höltl

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22278360%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

26 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22278360%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

21 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22278360%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22278360%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22278360%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

1407-1413

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22278360%20AND%20SRC:MED&resulttype=core&format=json

Update on the medical treatment of metastatic renal cell carcinoma

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

Toxicities of targeted therapy and their management in kidney cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

Targeted therapies for metastatic renal cell carcinoma: an overview of toxicity and dosing strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

Vaccination strategies in patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

Vaccine therapy in patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

Lasker Basic Medical Research Award. Dendritic cells: versatile controllers of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

The use of dendritic cells in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

Therapeutic dendritic cell vaccination of patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

Immunotherapy for prostate cancer: biology and therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

Mature dendritic cells induce T-helper type-1-dominant immune responses in patients with metastatic renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

Antigen-independent immune responses after dendritic cell vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

Rapid deterioration in quality of life during interleukin-2- and alpha-interferon-based home therapy of renal cell carcinoma is associated with a good outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

Quality of life in patients with metastatic renal cell carcinoma: the importance of patient-reported outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

Impact of sorafenib on health-related quality of life in Japanese patients with metastatic renal cell carcinoma: a prospective evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

Beyond traditional outcomes: improving quality of life in patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

Associations between physical activity and quality of life in a population-based sample of kidney cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

Basic research in kidney cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1207-7

10.1007/S00262-012-1207-7

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22278360%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference